Introduction
The 0-antigenic determinants are located in the It is generally agreed that a live attenuated vaccine endows mice with a greater degree of protection against murine salmonellosis than a nonviable one because of its ability to induce both the cellular and the humoral immune responses (Collins, 1974) . Nevertheless, it has also been established in mice that non-viable salmonella vaccines, which induce mainly a humoral immune response, can provide significant protection against a salmonella infection that would be lethal for unprotected mice (Eisenstein and Angerman, 1978; Kuusi et al., 1979; Svenson et al., 1979; Angerman and Eisenstein, 1980; Nakoneczna and Hsu, 1983; Hsu et al., 1985; Killion and Morrison, 1986) .
We have reported previously that both a heatkilled salmonella vaccine (Nakoneczna and Hsu, 1983) and its sonicated fragments (Hsu et al., 1985) are highly effective in protecting susceptible mice against challenge doses of > lo3 x LD50 of the homologous strain. The sonicated vaccine appeared to contain primarily large fragments of the bacterial envelope with little or no contamination with other components of the bacterial cell. Its immunogenic property is most likely attributable to the 0-antigens.
polysaccharide chains of the lipopolysaccharide (LPS) of the bacterial envelope. Recent studies have suggested that prior immunisation with LPS and other non-viable vaccines can be effective in protecting strains of mice that are naturally resistant to salmonella infection (Eisenstein et al., 1984) . Killion and Morrison (1986) reported that when mice of the salmonella-hypersusceptible strain C3H/HeJ were immunised with LPS-lipid Aassociated protein, they became effectively protected against a 103-fold lethal dose of Salmonella typhimurium. However, the inherent endotoxic effect of these LPS vaccines limits their potential use in man. Consequently, a vaccine was prepared by the covalent attachment of oligosaccharides from salmonella 0-specific antigens to carrier molecules (Svenson et al., 1979) . Unfortunately, the vaccine was tested on mice relatively resistant to salmonella infection and the protection afforded by it was only approximately 10 x LD50. Therefore, the vaccine was not considered to be a potent protective immunogen.
Several studies have demonstrated that treatment of enterobacterial LPS with alkali reduces its toxicity without destroying its 0-antigenic determinants (Niwa et al., 1969; von Eschen and Rudbach, 1976; Seid and Sadoff, 1981) . In the present study, the efficacy of detoxified LPS as a protective vaccine in mice susceptible to salmonella infection was determined and the possible mechanism of its protective immunity was assessed.
Preparations of LPS and detoxijied LPS (D-LPS)
The LPS was extracted from heat-killed S. typhimurium SR-11 by the hot phenol-water procedure of Westphal and Jann (1965) . The phenol-water extract was dialysed exhaustively against running tap water for 1 week and then against distilled water for 2 days with three daily changes. The dialysed LPS extract was lyophilised for storage. The LPS was partially delipidated by alkaline hydrolysis in 0.15 N NaOH for 2 h at 100°C (D-LPS). The preparation was adjusted to pH 3.5 by the addition of 1 N HC1 and free fatty acids were extracted with chloroform. The aqueous phase was separated, its pH adjusted to 7.0, and dialysed exhaustively against distilled water for 4 days before being lyophilised (Svenson and Lindberg, 1978) . As a result, the LPS and D-LPS preparations contained no detectable protein as measured by the assay of Lowry et al. (1951) . A commercial preparation of LPS from S. typhimurium (Sigma) was used for reference whenever indicated.
Characterisation of vaccines
Toxicity. The endotoxic property of LPS and D-LPS was determined by the Limulus amoebocyte lysate test as described by Seid et al. (1980) . Briefly, 1 mg of LPS or D-LPS was dissolved in 10 ml of pyrogen-free water (Sigma) with the aid of a Vortex mixer. Serial 10-fold dilutions of this preparation were made in pyrogen-free water, and 0.1 ml of each dilution was added to 0-1-ml amounts of Limulus lysate (Sigma) in pyrogen-free tubes. After gentle mixing, the tubes were incubated at 37°C for 1 h. The formation of a solid clot, as determined by inversion of each tube, was considered to be a positive reaction. SDS-PAGE. Polyacrylamide gels were prepared and run with the buffer system of Laemmli (1970) . Separating gels were formed with acrylamide 15% and SDS 0.1%, and a stacking gel with acrylamide 7.5% and SDS 0.1%. Samples of antigens were mixed with an equal volume of sample buffer (containing SDS 4%) and boiled for 2 min. Samples of 10-or 2 0 4 were applied to the gel. Electrophoresis was performed at a constant current of 15 mA per gel until the tracking dye entered the separating gel and then 25 mA per gel until the tracking dye reached the bottom of the gel. LPS and D-LPS bands were detected by the silver-staining method of Tsai and Frasch (1982) .
Vaccination and challenge infection of mice
Mice were immunised with three doses of 0.2ml of LPS or D-LPS in saline given by i.p. injection at weekly intervals. Control mice were given saline alone. On the 21st day after the first vaccination, groups of control and vaccinated mice were challenged i.p. with 0.2 ml of suspensions of S. typhimurium SR-11 containing 2 x lo2, 2 x lo3 or 2 x lo4 bacteria. The relative degree of protection afforded by each vaccine was determined by the number of mice surviving over a 3-week period of daily observation.
Determination of bacteraemia in infected mice
At intervals between 3 and 21 days after infection, mice selected at random from the control and vaccinated groups were killed by chloroform in a jar. Approximately 0-1 ml of blood was withdrawn directly with a syringe and needle from the exposed heart and inoculated into a tube of TSB and streaked on TSA. Bacterial growth was determined after incubation for 24 h at 37°C. Confirmation of the presence of salmonella colonies was by slide agglutination tests with salmonella group B antiserum (Lederle Diagnostics).
Preparation of tissue specimens from infected mice for his tological examination
At intervals of 3, 5, 9, 12, 21 and 28 days after the challenge infection, randomly selected control and vaccinated mice were killed. Tissue samples were removed from the liver, spleen, inguinal lymph nodes, lungs and heart, fixed in 10% phosphate-buffered formalin and embedded in paraffin. Sections of the tissues (5-7pm thick) were cut and stained with haematoxylin and eosin (H & E) for histological examination.
Results

Characterisation of LPS and D-LPS vaccines
Silver staining of LPS from S. typhimurium SR-11 separated by SDS-PAGE revealed a progressive ladder-like pattern of bands up the gel ( fig. 1 , lanes 5 and 6). These bands represent LPS molecules containing increasing lengths of the 0-antigenic side chains (Goldman and Leive, 1980; Palva and Makela, 1980) . The D-LPS bands (lanes 2,3 and 4) travelled further in electrophoresis than the LPS, suggesting that the size of the molecules was reduced by alkaline deacylation through the removal of the ester-linked fatty acids (Seid and Sadoff, 1981) . Preservation of the original ladder pattern indicated that the polysaccharide chains of D-LPS were not removed by alkali treatment.
On a comparative weight basis, D-LPS was lo3-fold less active than untreated LPS in causing Limulus amoebocyte lysate to gel (table) .
Protective eflect of LPS and D-LPS against salmonella infections
In preliminary tests, C3H/HeNMTV mice immunised with two doses of 15 pg of D-LPS 2 weeks apart were not protected against an i.p. challenge with 2 x lo4 salmonellae a week later. When the immunisation regimen was changed to one 200-pg dose of D-LPS, followed by two doses of 1OOpg given 10 days apart, 50% of the mice survived a challenge with 2 x lo4 organisms given 2 weeks later. This suggested that the efficacy of the D-LPS vaccine was dose dependent. C3H/HeNMTV mice were then immunised either by i.p. injection of 50 pg of LPS, followed by two booster injections of 25 pg of LPS at weekly intervals, or by injection of 300pg of D-LPS, followed by two injections of 150 pg of D-LPS at weekly intervals. Three weeks after the first immunisation, these mice, together with the unimmunised controls, were challenged by i.p. injection of 2 x lo2, 2 x lo3 or 2 x lo4 live cells of virulent S . typhimurium SR-11. The survival time of the mice in each group was recorded daily over a 3-week period as shown in fig. 2 . All the control mice challenged with the bacteria developed a severe, progressive disease and died between 5 and 12 days after infection. However, immunisation with LPS resulted in 100% protection against challenge with 2 x lo2 bacteria, and 90% and 70% survival after infection with 2 x lo3 and 2 x lo4 bacteria, respectively. Similarly, immunisation with D-LPS protected nearly all of the mice from the same challenges. Furthermore, immunisation prolonged the survival time of those mice that eventually died. The data demonstrate that both LPS and D-LPS can be effective in protecting C3H/HeNMTV mice against a lethal dose of S . typhimurium.
Bacteraemia in infected mice
From day 3, when blood samples were first taken, all samples from the infected control mice consistently yielded heavy bacterial growth both in TSB and on TSA plates. However, only transient bacteraemias were detected in most of the vaccinated mice during the first 9 days after the infection. From then on, the blood samples of the vaccinated mice showed no growth in both culture media. With one exception, the samples from the two LPSvaccinated mice infected with 2 x lo4 bacteria and killed on days 5 and 9, respectively, yielded a heavy growth in both culture media.
Histological evidence of protective immunity by D-LPS vaccine
As shown in fig. 2 , the C3H/HeNMTV mice were highly susceptible to infection with S . typhimurium SR-11. A challenge dose of 2 x lo2 organisms resulted in an inevitably fatal disease within 12 days. Histopathological findings in the tissue specimens taken from these mice 3, 9 and 12 days after infection were consistent with those described previously in detail (Nakoneczna and Hsu, 1983; Hsu et al., 1985) .
Post-mortem examination of the control mouse infected with 2 x lo4 bacteria and killed at day 3 revealed marked congestion of all internal organs. Small solitary abscesses were scattered throughout the liver and spleen. Numerous neutrophils filled the subcapsular sinuses of the spleen. Small numbers of mixed neutrophils and mononuclear cells were present in liver sinusoids and in the pulmonary interstitium. The terminally sick mice killed 9 and 12 days after infection showed severe generalised disease. The morphological findings were identical in all control mice irrespective of the size of the challenge dose. There was extensive involvement of both liver and spleen. Occlusive organising thrombi in portal and central veins were associated with large areas of necrosis in the liver. Numerous, and often confluent, granulomas and prominent nodular aggregates of Kupffer cells and macrophages were present in dilated sinusoids ( fig. 3) . Many sinusoids were occluded by small granulomas. In the spleen, there was severe distortion of the architectural pattern with densely packed, frequently confluent, granulomas and scattered small acute abscesses. Sheets of polymorphonuclear leucocytes filled subcapsular sinuses and extended along the splenic trabeculae. Severe granulomatous pneumonitis and focal acute myopericarditis were also seen in some mice.
In contrast, vaccinated mice examined 3 days after infection showed only mild acute congestion, few scattered solitary acute micro-abscesses ( fig. 4) , rare small areas of necrosis, and occasional mural thrombi in their livers and spleens. In those inoculated with 2 x lo2 and 2 x lo3 salmonellae, the disease progressed slowly and seemed to reach its peak 5 days after the inoculation. Post-mortem examination at that time disclosed only a mild to moderate increase in size and number of acute lesions and the emergence of early and transitional granulomas, as well as mononuclear cell infiltrates in both liver and spleen.
Vaccinated mice examined 9 days after infection were either free from any pathological changes or showed a few scattered solitary micro-abscesses and transitional granulomas. Similarly, those examined 21 and 28 days after infection were either free from any abnormal change or presented with very mild chronic disease consisting of a few minute granulomas and occasional organising small infarcts.
The group of vaccinated mice inoculated with 2 x lo4 salmonellae revealed similar, but more severe pathological changes than in those inoculated with fewer pathogens. In addition to them having a greater number of lesions, the transition from acute to chronic state was delayed until 9-12 days ( fig. 5 ) and then persisted at a plateau for another 1-2 weeks, slowly resolving thereafter. On examination 28 days after infection, only a few small clusters of mononuclear cells within some of the liver sinusoids and portal areas were seen. Capsular fibrosis and mixed cell infiltrates were present in subcapsular sinuses and in peritrabecular areas of the spleen.
Discussion
Recent research in murine salmonellosis has in part focused on the delineation of the antigens responsible for the induction of immunity and the immune mechanisms contributing to the elimination of the pathogen by the host following the infection. We have reported that both the heatkilled salmonella vaccine, which does not contain the H-antigen (Nakoneczna and Hsu, 1983) , and its sonicated fragments, which presumably consist of bacterial outer envelopes (Hsu et al., 1985) , are very effective in protecting highly susceptible mice against a subsequent challenge. It is reasonable to assume that the protective antigens in these two vaccine preparations are associated with the 0-antigens.
The data obtained in this investigation indicate that the salmonella-susceptible C3H/HeNMTV mice can be protected to a significant extent against a lethal challenge with S. typhimurium SR-11 by immunisation with LPS or D-LPS derived from the homologous organism. The level of protection was dose dependent. Complete protection against a lethal challenge with 2 x lo4 bacteria was achieved with the D-LPS when the immunisation regimen consisted of an initial dose of 300 pg, followed by two doses of 150 pg each given 1 week apart. Protection was diminished to 50% when the regimen was changed to 200pg, followed by two doses of 1OOpg given 10 days apart. A further reduction to two vaccinations each of 15 pg given 2 weeks apart was not protective. Although both LPS and D-LPS were immunogenic and protective, approximately 6-to 10-fold more D-LPS than LPS, by weight, was needed to protect mice to an equivalent degree. It is possible that the lipid-A portion in the LPS molecule exerts an adjuvant effect to enhance the antibody response in the host.
The LPS isolated from S . typhimurium strain SR-11 was found to be immunogenic and protective in mice in the present study. However, for practical application as a vaccine in man, the inherent endotoxic effect of LPS needs to be considered. By using the method described by Svenson and Lindberg (1 9719, we partially delipidated the LPS with alkali. On a comparative weight basis, it was 103-fold less toxic than untreated LPS, as determined by the Limulus amoebocyte assay for the detection of endotoxins (Seid et al., 1980) . In spite of its reduced molecular size, the D-LPS appeared to share the same 0-polysaccharide portion with the LPS, as seen by the silver-staining of the D-LPS and LPS preparations after SDS-PAGE ( fig. 1) . The stained antigens revealed virtually the same progressive ladder-like pattern, indicating that the polysaccharide chains of D-LPS were not altered by alkali treatment. The observation that both the LPS and the D-LPS can protect mice from lethal salmonellosis would support the role of 0-antigens as effective immunogens. On the other hand, purified oligosaccharides derived from 0-specific antigens of salmonellae are not potent protective immunogens (Svenson et al., 1979; Svenson and Lindberg, 1981) . It is possible that the molecular size of the oligosaccharides may be too small for them to be effective immunogens.
There has been considerable debate in published reports on the role of anti-0 antibodies in protection against salmonellosis (Collins, 1974; Svenson et al., 1979 ; Angerman and Eisenstein, 1980 ; Eisenstein and Sultzer, 1983; Eisenstein et al., 1984; Hsu et al., 1985) . However, it is agreed generally that nonviable vaccines induce only humoral immunity against salmonellosis (Eisenstein and Sultzer, 1983 ; Nakoneczna and Hsu, 1983) . This can be discerned by the early formation of acute, self-limiting abscesses in the infected mice protected by nonviable vaccines (Nakoneczna and Hsu, 1983; Hsu et al., 1985) , in contrast to the early formation of granulomas in those protected by live vaccines (Nakoneczna and Hsu, 1980) . The latter lesions are manifestations of delayed hypersensitivity to bacterial antigens. The histopathological features observed in this investigation are consistent with those reported previously in mice protected by nonviable vaccines. The control mice died from salmonellosis because the acute inflammatory infiltration of polymorphonuclear leucocytes early in the infectious process was incapable of suppressing the bacterial proliferation in the tissues, while the enlarging and confluent abscesses led to extensive tissue destruction ( fig. 3a) . In contrast, the initial acute inflammatory reaction in mice protected with the LPS or the D-LPS vaccine ( fig. 4) was considerably milder, probably because of the successful containment of bacterial multiplication. This was undoubtedly a manifestation of the beneficial effect of opsonic antibodies (Wells and Hsu, 1970), which facilitated the bactericidal action of the inflammatory cells (Guo et al. 1986) . The ability to localise the pathogen at the site of inoculation as well as at the site of early lesions clearly delayed the dissemination and proliferation of the bacteria, as evidenced, in part, by the absence of bacteraemia in the infected but vaccinated mice. It also allowed time for the host to mount its anamnestic humoral response and to induce delayed hypersensitivity against the bacterial protein antigens, which was
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